146 related articles for article (PubMed ID: 36335669)
1. Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis.
Xu S; Yang X; Chen Q; Liu Z; Chen Y; Yao X; Xiao A; Tian J; Xie L; Zhou M; Hu Z; Zhu F; Xu X; Hou F; Nie J
EBioMedicine; 2022 Dec; 86():104312. PubMed ID: 36335669
[TBL] [Abstract][Full Text] [Related]
2. The ILEI/LIFR complex induces EMT via the Akt and ERK pathways in renal interstitial fibrosis.
Zhou J; Jiang H; Jiang H; Fan Y; Zhang J; Ma X; Yang X; Sun Y; Zhao X
J Transl Med; 2022 Jan; 20(1):54. PubMed ID: 35093095
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure.
Yoshino J; Monkawa T; Tsuji M; Hayashi M; Saruta T
J Am Soc Nephrol; 2003 Dec; 14(12):3090-101. PubMed ID: 14638908
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway.
Zhang W; Rong G; Gu J; Fan C; Guo T; Jiang T; Deng W; Xie J; Su Z; Yu Q; Mai J; Zheng R; Chen X; Tang X; Zhang J
FASEB J; 2022 Mar; 36(3):e22084. PubMed ID: 35107844
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of ZAK ameliorates renal interstitial fibrosis.
Shu S; Liu H; Yang J; Tang H; Li H; Liu Z; Zhou M; Zhu F; Hu Z; Ding K; Lu X; Nie J
Transl Res; 2022 Aug; 246():49-65. PubMed ID: 35276386
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the role of nicotinamide N-methyltransferase-p53 axis in the progression of chronic kidney disease.
Zhen X; Sun Y; Lin H; Huang Y; Liu T; Li Y; Peng H
PeerJ; 2023; 11():e16301. PubMed ID: 37953778
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c.
Yu Y; Wang Y; Niu Y; Fu L; Chin YE; Yu C
Am J Physiol Renal Physiol; 2015 Oct; 309(7):F595-603. PubMed ID: 26155847
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.
Mizuno S; Matsumoto K; Nakamura T
Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391
[TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog is a novel tubule-derived growth factor for interstitial fibroblasts after kidney injury.
Zhou D; Li Y; Zhou L; Tan RJ; Xiao L; Liang M; Hou FF; Liu Y
J Am Soc Nephrol; 2014 Oct; 25(10):2187-200. PubMed ID: 24744439
[TBL] [Abstract][Full Text] [Related]
11. Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease.
Mirzoyan K; Baïotto A; Dupuy A; Marsal D; Denis C; Vinel C; Sicard P; Bertrand-Michel J; Bascands JL; Schanstra JP; Klein J; Saulnier-Blache JS
J Physiol Biochem; 2016 Dec; 72(4):803-812. PubMed ID: 27637780
[TBL] [Abstract][Full Text] [Related]
12. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
13. Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment.
Peng Y; Li L; Shang J; Zhu H; Liao J; Hong X; Hou FF; Fu H; Liu Y
Theranostics; 2023; 13(11):3897-3913. PubMed ID: 37441594
[No Abstract] [Full Text] [Related]
14. Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis via MDM2.
He FF; You RY; Ye C; Lei CT; Tang H; Su H; Zhang C
Cell Physiol Biochem; 2018; 46(2):451-460. PubMed ID: 29614506
[TBL] [Abstract][Full Text] [Related]
15. Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells.
Luo C; Zhou S; Zhou Z; Liu Y; Yang L; Liu J; Zhang Y; Li H; Liu Y; Hou FF; Zhou L
J Am Soc Nephrol; 2018 Apr; 29(4):1238-1256. PubMed ID: 29440280
[TBL] [Abstract][Full Text] [Related]
16. Isoandrographolide from Andrographis paniculata ameliorates tubulointerstitial fibrosis in ureteral obstruction-induced mice, associated with negatively regulating AKT/GSK-3β/β-cat signaling pathway.
Guan Z; Wang Y; Xu H; Wang Y; Wu D; Zhang Z; Liu Z; Shang N; Zhang D; Sun J; He X; Li Y; Zhu L; Liu Z; Zhang M; Xu Z; Song Z; Dai G
Int Immunopharmacol; 2022 Nov; 112():109201. PubMed ID: 36067652
[TBL] [Abstract][Full Text] [Related]
17. Microparticles derived from human erythropoietin mRNA-transfected mesenchymal stem cells inhibit epithelial-to-mesenchymal transition and ameliorate renal interstitial fibrosis.
Lee M; Kim SH; Jhee JH; Kim TY; Choi HY; Kim HJ; Park HC
Stem Cell Res Ther; 2020 Sep; 11(1):422. PubMed ID: 32993806
[TBL] [Abstract][Full Text] [Related]
18. Suppression of LMCD1 ameliorates renal fibrosis by blocking the activation of ERK pathway.
Yu R; Tian M; He P; Chen J; Zhao Z; Zhang Y; Zhang B
Biochim Biophys Acta Mol Cell Res; 2022 Apr; 1869(4):119200. PubMed ID: 34968577
[TBL] [Abstract][Full Text] [Related]
19. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
[TBL] [Abstract][Full Text] [Related]
20. RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice.
Zhou Z; Ni J; Li J; Huo C; Miao N; Yin F; Cheng Q; Xu D; Xie H; Chen P; Zheng P; Zhang Y; Zhou L; Zhang W; Yu C; Liu J; Lu L
J Mol Med (Berl); 2020 Apr; 98(4):527-540. PubMed ID: 32036390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
